• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对多阶段疾病进展的面板研究设计。

Design of panel studies for disease progression with multiple stages.

作者信息

Hwang Wei-Ting, Brookmeyer Ron

机构信息

Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 628 Blockley Hall, 423 Guardian Drive, Philadelphia, Pennsylvania 19104, USA.

出版信息

Lifetime Data Anal. 2003 Sep;9(3):261-74. doi: 10.1023/a:1025884719728.

DOI:10.1023/a:1025884719728
PMID:14649845
Abstract

A panel study consists of individuals who have data collected at periodic follow-up visits or pre-specified time points following entry into the study. The objective of this paper is to consider design issues in a panel study when the response variable is the stage of disease, and with focus on the transition intensities. Important design issues include the choice of the time interval between follow-up visits and sample size considerations. We study the effects of time intervals between follow-up visits on the precision of the transition intensities estimators. We also consider the power of statistical tests on the ratio of transition intensities. Discussion is extended to incorporate heterogeneity in the population in which frailty is introduced to describe subject-specific transition intensities.

摘要

一项面板研究由在进入研究后定期随访或预先指定时间点收集数据的个体组成。本文的目的是在响应变量为疾病阶段且重点关注转移强度的情况下,考虑面板研究中的设计问题。重要的设计问题包括随访之间时间间隔的选择和样本量的考虑。我们研究随访之间时间间隔对转移强度估计精度的影响。我们还考虑了关于转移强度比率的统计检验的功效。讨论扩展到纳入人群中的异质性,其中引入脆弱性来描述个体特定的转移强度。

相似文献

1
Design of panel studies for disease progression with multiple stages.针对多阶段疾病进展的面板研究设计。
Lifetime Data Anal. 2003 Sep;9(3):261-74. doi: 10.1023/a:1025884719728.
2
Statistical issues in periodontal research.牙周病研究中的统计学问题。
J Dent Res. 1995 Nov;74(11):1731-7. doi: 10.1177/00220345950740110301.
3
A review of statistical issues with progression-free survival as an interval-censored time-to-event endpoint.以无进展生存期作为区间删失的事件发生时间终点的统计问题综述。
J Biopharm Stat. 2013;23(5):986-1003. doi: 10.1080/10543406.2013.813524.
4
Likelihood inference on the relative risk in split-cluster designs.分裂型群组设计中相对风险的似然推断。
Clin Trials. 2011 Feb;8(1):37-47. doi: 10.1177/1740774510392254.
5
Composite likelihood for joint analysis of multiple multistate processes via copulas.通过copulas对多个多状态过程进行联合分析的复合似然法。
Biostatistics. 2014 Oct;15(4):690-705. doi: 10.1093/biostatistics/kxu011. Epub 2014 Apr 9.
6
Phase specific analysis of herpes zoster associated pain data: a new statistical approach.带状疱疹相关性疼痛数据的阶段特异性分析:一种新的统计方法。
Stat Med. 2001 Aug 30;20(16):2429-39. doi: 10.1002/sim.851.
7
Pseudo and conditional score approach to joint analysis of current count and current status data.用于当前计数和当前状态数据联合分析的伪分数和条件分数方法。
Biometrics. 2018 Dec;74(4):1223-1231. doi: 10.1111/biom.12880. Epub 2018 Apr 17.
8
Sample size planning of two-arm superiority and noninferiority survival studies with discrete follow-up.
Stat Med. 2017 Sep 10;36(20):3123-3136. doi: 10.1002/sim.7360. Epub 2017 Jun 12.
9
A joint model for the dependence between clustered times to tumour progression and deaths: A meta-analysis of chemotherapy in head and neck cancer.一种用于肿瘤进展时间和死亡时间聚集性依赖关系的联合模型:头颈部癌化疗的荟萃分析。
Stat Methods Med Res. 2015 Dec;24(6):711-29. doi: 10.1177/0962280211425578. Epub 2011 Oct 23.
10
An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.对具有预先指定样本量修改规则的适应性临床试验设计的推断程序的评估。
Biometrics. 2014 Sep;70(3):556-67. doi: 10.1111/biom.12168. Epub 2014 Apr 25.

引用本文的文献

1
Progress and challenges in potential access to oral health primary care services in Brazil: A population-based panel study with latent transition analysis.巴西获取口腔基本医疗保健服务的进展与挑战:基于人口的潜类别转移分析面板研究。
PLoS One. 2021 Mar 16;16(3):e0247101. doi: 10.1371/journal.pone.0247101. eCollection 2021.
2
Information measures and design issues in the study of mortality deceleration: findings for the gamma-Gompertz model.信息测度与死亡率减速研究中的设计问题:伽玛-戈珀兹模型的发现。
Lifetime Data Anal. 2021 Jul;27(3):333-356. doi: 10.1007/s10985-021-09518-4. Epub 2021 Feb 25.
3
Estimation and assessment of markov multistate models with intermittent observations on individuals.

本文引用的文献

1
Fitting semi-Markov models to interval-censored data with unknown initiation times.将半马尔可夫模型拟合到起始时间未知的区间删失数据。
Biometrics. 1999 Jun;55(2):507-13. doi: 10.1111/j.0006-341x.1999.00507.x.
2
Estimating the extent of tracking in interval-censored chain-of-events data.估计区间删失的事件链数据中的追踪范围。
Biometrics. 1999 Dec;55(4):1228-31. doi: 10.1111/j.0006-341x.1999.01228.x.
3
Fisher information for two gamma frailty bivariate Weibull models.两个伽马脆弱双变量威布尔模型的费希尔信息
对个体进行间歇性观测的马尔可夫多状态模型的估计与评估。
Lifetime Data Anal. 2015 Apr;21(2):160-79. doi: 10.1007/s10985-014-9310-z. Epub 2014 Oct 21.
Lifetime Data Anal. 2000 Mar;6(1):59-71. doi: 10.1023/a:1009614001583.
4
The Clinical Dementia Rating (CDR): current version and scoring rules.临床痴呆评定量表(CDR):当前版本及评分规则。
Neurology. 1993 Nov;43(11):2412-4. doi: 10.1212/wnl.43.11.2412-a.
5
Evaluating serial cancer marker studies in patients at risk of recurrent disease.评估复发性疾病风险患者的系列癌症标志物研究。
Biometrics. 1981 Mar;37(1):67-78.
6
A new clinical scale for the staging of dementia.一种用于痴呆分期的新临床量表。
Br J Psychiatry. 1982 Jun;140:566-72. doi: 10.1192/bjp.140.6.566.
7
Heterogeneity in survival analysis.生存分析中的异质性。
Stat Med. 1988 Nov;7(11):1121-37. doi: 10.1002/sim.4780071105.
8
Statistical analysis of the stages of HIV infection using a Markov model.使用马尔可夫模型对HIV感染阶段进行统计分析。
Stat Med. 1989 Jul;8(7):831-43. doi: 10.1002/sim.4780080708.
9
A Markov model for analysing cancer markers and disease states in survival studies.一种用于在生存研究中分析癌症标志物和疾病状态的马尔可夫模型。
Biometrics. 1986 Dec;42(4):855-65.
10
Sampling design of multiwave studies with an application to the Massachusetts Health Care Panel Study.
Stat Med. 1991 Dec;10(12):1945-58. doi: 10.1002/sim.4780101209.